ALFA Filings
Every announcement, straight from the exchange
Every Lupin merger & restructuring announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
Lupin Limited's step-down subsidiary, Multicare Pharmaceuticals Philippines, Inc., completed a buyback of 30,559 shares. MPPI is now a wholly owned step-down subsidiary of the Company.
Lupin Inc. licensed two oncology programs to Kaveri Therapeutics in exchange for an 82.2% stake, valued at ₹15.36 Crore.
Lupin's subsidiary Nanomi completed the acquisition of shares in MPPI. This increases Nanomi's effective shareholding in MPPI to 99.89%.